General MedicationsORALGeneric
TARACTAN
CHLORPROTHIXENE
Standard Dose
100MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview TARACTAN is listed in Drugs@FDA under application 012486 (NDA).
Marketing status: Discontinued Active ingredient CHLORPROTHIXENE Form and strength TABLET;ORAL - 100MG Sponsor ROCHE Submission history Latest submission status date: 1997-01-09 00:00:00.
Structured Monograph
Clinical summary
Approval overview TARACTAN is listed in Drugs@FDA under application 012486 (NDA). Marketing status: Discontinued Active ingredient CHLORPROTHIXENE Form and strength TABLET;ORAL - 100MG Sponsor ROCHE Submission history Latest submission status date: 1997-01-09 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.